Atsushi Kikuchi Selected Research

Iodine-123

1/2022	Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.
1/2021	Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure.
1/2020	Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction.
12/2015	Risk stratification of patients with chronic heart failure using cardiac iodine-123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Kikuchi Research Topics

Disease

13	Heart Failure 01/2022 - 06/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Ventricular Tachycardia 12/2019 - 12/2015
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2019 - 06/2015
2	Hypertension (High Blood Pressure) 01/2019 - 10/2017
2	Hypertrophy 08/2006 - 08/2005
2	Sleep Apnea Syndromes (Sleep Apnea) 08/2006 - 08/2005
1	Thrombosis (Thrombus) 01/2022
1	Death (Near-Death Experience) 01/2022
1	Neointima 08/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Weight Loss (Weight Reduction) 01/2020
1	Body Weight Changes 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Endocarditis 11/2019
1	Meningitis 11/2019
1	Respiratory Insufficiency (Respiratory Failure) 11/2019
1	Septic Shock (Toxic Shock Syndrome) 11/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2019
1	Diabetes Mellitus 01/2019
1	Malnutrition (Nutritional Deficiencies) 01/2019
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Atrial Fibrillation 10/2017
1	Fibrosis (Cirrhosis) 10/2017
1	Obstructive Sleep Apnea 08/2014
1	Multiple System Atrophy 12/2012
1	Respiratory Sounds (Crackle) 12/2012
1	Breast Neoplasms (Breast Cancer) 09/2012
1	Pathologic Constriction (Stenosis) 08/2006

Drug/Important Bio-Agent (IBA)

7	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022 - 06/2015
4	Iodine-123IBA 01/2022 - 12/2015
2	Tolvaptan FDA Link 01/2020 - 04/2017
2	DiureticsIBA 01/2020 - 04/2017
1	tyramine-deoxysorbitolIBA 01/2022
1	LipidsIBA 08/2021
1	empagliflozinIBA 01/2021
1	SteroidsIBA 11/2019
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	AlbuminsIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	SodiumIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	NitrogenIBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Urea (Carbamide)FDA LinkGeneric 01/2019
1	Cholinesterases (Cholinesterase)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	ChloridesIBA 01/2018
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2017
1	Eplerenone (Inspra)FDA LinkGeneric 10/2017
1	Radioisotopes (Radionuclides)IBA 06/2013
1	Hormones (Hormone)IBA 09/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 09/2012

Therapy/Procedure

8	Therapeutics 01/2021 - 08/2005
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2019 - 12/2015
3	Continuous Positive Airway Pressure 12/2012 - 08/2005
2	Tonsillectomy 08/2014 - 08/2006
1	Stents 01/2022
1	Cardiac Rehabilitation 01/2021
1	Telerehabilitation 01/2021
1	Punctures 11/2019
1	Defibrillators (Defibrillator) 06/2015
1	Tracheostomy 12/2012
1	Lasers (Laser) 12/2012